Veradigm Inc (MDRX)
7.55
0.00 (0.00%)
USD |
OTCM |
Apr 18, 15:59
Veradigm Research and Development Expense (Quarterly): 23.68M for Sept. 30, 2022
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 23.68M |
| June 30, 2022 | 22.75M |
| March 31, 2022 | 23.42M |
| December 31, 2021 | 131.03M |
| September 30, 2021 | 21.04M |
| June 30, 2021 | 20.94M |
| March 31, 2021 | 20.66M |
| December 31, 2020 | 54.29M |
| September 30, 2020 | 46.35M |
| June 30, 2020 | 46.04M |
| March 31, 2020 | 59.38M |
| December 31, 2019 | 53.85M |
| September 30, 2019 | 63.87M |
| June 30, 2019 | 63.41M |
| March 31, 2019 | 64.31M |
| December 31, 2018 | 56.42M |
| September 30, 2018 | 63.03M |
| June 30, 2018 | 74.49M |
| March 31, 2018 | 64.79M |
| December 31, 2017 | 55.53M |
| September 30, 2017 | 51.06M |
| June 30, 2017 | 46.46M |
| March 31, 2017 | 49.23M |
| December 31, 2016 | 38.46M |
| September 30, 2016 | 45.14M |
| Date | Value |
|---|---|
| June 30, 2016 | 47.89M |
| March 31, 2016 | 47.04M |
| December 31, 2015 | 46.00M |
| September 30, 2015 | 47.70M |
| June 30, 2015 | 44.37M |
| March 31, 2015 | 46.73M |
| December 31, 2014 | 41.54M |
| September 30, 2014 | 45.96M |
| June 30, 2014 | 53.02M |
| March 31, 2014 | 52.30M |
| December 31, 2013 | 47.87M |
| September 30, 2013 | 49.40M |
| June 30, 2013 | 51.82M |
| March 31, 2013 | 50.66M |
| December 31, 2012 | 49.99M |
| September 30, 2012 | 37.80M |
| June 30, 2012 | 38.24M |
| March 31, 2012 | 36.12M |
| December 31, 2011 | 31.31M |
| September 30, 2011 | 26.03M |
| June 30, 2011 | 24.76M |
| March 31, 2011 | 22.00M |
| September 30, 2010 | 16.70M |
| May 31, 2010 | 13.86M |
| February 28, 2010 | 12.65M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
20.66M
Minimum
Mar 2021
131.03M
Maximum
Dec 2021
46.48M
Average
46.20M
Median
Research and Development Expense (Quarterly) Benchmarks
| LifeMD Inc | 1.998M |
| TruBridge Inc | 10.35M |
| Streamline Health Solutions Inc | 1.304M |
| PetMed Express Inc | -- |
| LENZ Therapeutics Inc | -- |